Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02847130 · ClinicalTrials.gov registry record
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 530
- Enrollment target
NCT02847130: Completed study, sponsored by Children's Oncology Group.
NCT02847130 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 530 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02847130 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 530 participants
- Enrollment target
Study Summary
This research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them. The treatments for childhood cancers are intense and result in a high rate of symptoms which require support by healthcare providers. By reviewing patients' medical chart records, meeting in focus groups and in one-on-one interviews, healthcare providers may improve how clinical practice guidelines are used to support children undergoing cancer treatment.
Primary Outcome
FN will be identified by chart review. Outcome variable will be the binary endpoint of CPG-consistent versus (vs.) CPG inconsistent care for each FN episode.
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
- OTHER Interview
- OTHER Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 2016-11-21 |
| Est. Completion | 2023-06-30 |
What the finished NCT02847130 record still lists
NCT02847130 is an observational study that tracks outcomes without assigning an intervention. The registered 530 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT02847130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02847130 about?
NCT02847130 is a clinical study titled "Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology". This research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them. The treatments for childhood cancers are intense and result in a high rate of symptoms which require support by healthcare p...
What is the current status of trial NCT02847130?
This trial is currently completed. The enrollment target is 530 participants. The study started on 2016-11-21. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT02847130?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER), Interview (OTHER), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT02847130?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI